Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus
- 1 December 2015
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 161 (2) , 209-216
Abstract
No abstract availableKeywords
Funding Information
- Major International (Regional) Joint Research Project of China (81120108021)
- National Natural Science Foundation of China (81273304, 81401349)
- Fundamental Research Funds for the Central Universities of China (021414340284)
This publication has 44 references indexed in Scilit:
- Macrophage depletion ameliorates nephritis induced by pathogenic antibodiesJournal of Autoimmunity, 2015
- The M1 and M2 paradigm of macrophage activation: time for reassessmentF1000Prime Reports, 2014
- Structure and Function of Renal Macrophages and Dendritic Cells From Lupus‐Prone MiceArthritis & Rheumatology, 2014
- Apoptotic cell clearance: basic biology and therapeutic potentialNature Reviews Immunology, 2014
- Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicineExperimental & Molecular Medicine, 2013
- Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells – a rheumatoid arthritis mouse modelStem Cell Research & Therapy, 2013
- Functional Interaction of Cockroach Allergens and Mannose Receptor (CD206) in Human Circulating FibrocytesPLOS ONE, 2013
- Macrophage biology in development, homeostasis and diseaseNature, 2013
- Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosusArthritis & Rheumatism, 2010
- Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr miceLupus, 2010